BBH
VanEck Biotech ETF
3월 13일 4:00 PM ET (한국 3/14 05:00)
$186.60
-0.42 ▼ -0.23%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$186.60
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | - | Perf Week | -1.23% |
| Market Cap | - | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | - | Perf Month | -4.66% |
| Enterprise Value | - | PEG | - | EPS next Q | - | Inst Own | - | Short Float | - | Perf Quarter | -2.1% |
| Income | - | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 2.37 | Perf Half Y | 10.15% |
| Sales | - | P/B | - | EPS next 5Y | - | ROA | - | Short Interest | 0.02M | Perf YTD | -1.41% |
| Book/sh | - | P/C | - | EPS past 3/5Y | - | ROE | - | 52W High | -8.04% ($202.91) | Perf Year | 15.86% |
| Cash/sh | - | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 37.87% ($135.34) | Perf 3Y | 19.69% |
| Dividend Est. | $0.96 (0.51%) | EV/EBITDA | - | EPS Y/Y TTM | - | Gross Margin | - | Volatility(W/M) | 1.43% 1.3% | Perf 5Y | 7.23% |
| Dividend TTM | 0.96 | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 3.1 | Perf 10Y | 81.07% |
| Dividend Ex-Date | 2025/12/22 | Quick Ratio | - | EPS Q/Q | - | Profit Margin | - | RSI (14) | 37.46 | Recom | - |
| Dividend Gr. 3/5Y | 8.47% 9.47% | Current Ratio | - | Sales Q/Q | - | SMA20 | -3.81% ($193.99) | Beta | 0.81 | Target Price | - |
| Payout | - | Debt/Eq | - | Earnings | - | SMA50 | -4.13% ($194.64) | Rel Volume | 0.44 | Prev Close | $187.02 |
| Employees | - | LT Debt/Eq | - | EPS/Sales Surpr. | - | SMA200 | 5.66% ($176.6) | Avg Volume(3M) | 0.01M | Price | $186.6 |
| IPO | 2011/12/21 | Option/Short | Yes/Yes | Trades | 192 | Volume | 3,063 | Change | -0.23% |
뉴스 로딩 중...